Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01598818
Other study ID # 0553-11-FB
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 11, 2012
Est. completion date January 13, 2014

Study information

Verified date August 2023
Source University of Nebraska
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to test the efficacy of the First-Sight refractive kit designed to provide refractive correction of simple hyperopia, myopia and astigmatism with autorefraction.


Description:

In remote and underserved areas, a patient may have limited or no access to eye specialists or healthcare facilities that offer equipment to provide standard refraction and purchase corrective lenses. First Sight Refracting system (FSR) is designed specifically to be used in remote and underserved areas. FSR is not considered the standard of care in the US. FSR is a portable refraction and lens-frame dispensing system with low cost of production. As a kit, it contains +/- 6.00 diopters of corrective lenses, color coordinated flipper, - 1.25 diopter astigmatism lens, visual acuity chart, astigmatic eye chart, measuring tape to measure the distance of the subject to the eye charts, pupillary distance ruler to measure for the frame size of the glasses to be dispensed, and lint free gloves. The kit comes with two standard frames. The corrective lenses are designed to be placed in the frames that can be readily dispensed to the patient after the refraction is done. The refraction technique is simple and straightforward and any healthcare worker in remote and underserved areas can provide the test and dispense glasses at no cost. This is the third phase of First Sight refractive study to be done in Haiti. Adult and children subjects will be recruited during their routine examinations and/or visual acuity screenings at the Justinien Hospital. The proposed study will compare the visual acuity measurements obtained from the First Sight refraction system (test procedure) with the visual acuity measurements obtained from the autorefraction (standard care). The international study will recruit 150 subjects which will test FSR's effectiveness as a refracting tool of choice to be used in remote and underserved areas. Data from this study will be compared with the US studies.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date January 13, 2014
Est. primary completion date January 13, 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years to 50 Years
Eligibility Inclusion Criteria: - Subjects must be 7 years of age and older - Healthy subjects with no known ocular trauma, no surgery, ocular disease or pathology that would prevent obtainment of best correctable visual acuity to 20/30. Exclusion Criteria: - Refractive error greater than (+)/(-) 6.00 diopter, or astigmatism greater than 1.50 diopters. - Known ocular (corneal, lenticular, vitreal, or retinal) pathology that may limit best correctable visual acuity.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Haiti Justinien Hospital Cap-Haïtien
United States University of Nebraska Medical Center, Department of Ophthalmology Omaha Nebraska

Sponsors (1)

Lead Sponsor Collaborator
University of Nebraska

Countries where clinical trial is conducted

United States,  Haiti, 

Outcome

Type Measure Description Time frame Safety issue
Primary To compare the best visual acuity and refraction results using the First Sight Refraction System to standard auto-refraction in subjects with hyperopia. A refractive error of +0.50 to +4.50 diopter spherical error and asitgmatism of 1.50 diopters will be assessed. 1 month
Secondary To compare the best visual acuity and refraction results using the First Sight Refractive System to autorefraction in myopia. A refractive error of -0.50 to -4.50 diopter spherical error and up to 1.50 astigmatism will be compared. 1 month
See also
  Status Clinical Trial Phase
Completed NCT02862405 - Perception of Objects and Natural Scenes in People With Vision Loss (ACTIVIS) N/A
Completed NCT01838655 - Nitisinone for Type 1B Oculocutaneous Albinism Phase 1/Phase 2